NFKB1 and non-small cell lung carcinoma: Therefore, we reason that RNF25 functions as an essential mediator connecting NF-κB and ERK pathways, and its depletion disrupts this connection, thereby sensitizing the EGFR-mutant NSCLC cells to gefitinib treatment.